Enterprise Value
25.01M
Cash
44.98M
Avg Qtr Burn
-13.92M
Short % of Float
2.42%
Insider Ownership
13.42%
Institutional Own.
41.72%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ONCR-177 Details Solid tumor/s, Melanoma, Cancer, Breast cancer, Head and neck squamous cell carcinoma | Failed Discontinued |